The alternative fact of probable vaccine damage A typology of vaccination beliefs in 28 European countries
Simona Nicoleta Vulpe, Cosima Rughinis

TL;DR
This study analyzes vaccination beliefs across 28 European countries, revealing widespread misconceptions and identifying three distinct belief clusters, highlighting the persistence of vaccine hesitancy despite scientific evidence.
Contribution
It provides a typology of public vaccination beliefs based on survey data, illustrating the coexistence of skepticism, confidence, and trade-off perceptions.
Findings
Approximately 10% believe vaccines are not well-tested.
One-third believe vaccines can overload or cause the disease.
Nearly half think vaccines can cause serious side effects.
Abstract
Background: Despite lacking scientific support, vaccine hesitancy is widespread. While vaccine damage as a scientific fact is statistically highly uncommon, emerging social and technological forces have converted probable vaccine damage into an alternative fact. Methods: Using the Eurobarometer 91.2 survey on a statistically representative EU27-UK sample interviewed in March 2019, we documented perceptions of vaccine risks and identified three belief configurations regarding vaccine effectiveness, safety, and usefulness, through exploratory cluster analysis. Results: The public beliefs in vaccine risks are frequent. Approximatively one-tenth of the EU27-UK population consider vaccines are not rigorously tested before authorization, one-third believe vaccines can overload or weaken the immune system and that they can cause the disease against which they protect, and almost one-half…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsVaccine Coverage and Hesitancy · Psychology of Moral and Emotional Judgment · SARS-CoV-2 and COVID-19 Research
